Joy Ventures
Overview
Joy Ventures, which rebranded to Corundum Neuroscience in November 2023, is a venture builder and fund that invests in and supports early-stage companies with a focus on neuroscience. The firm's 'lab-to-life' model supports the entire innovation journey from research to commercialization, aiming to develop solutions for health and disease areas like anxiety, depression, PTSD, chronic pain, sleep, and neurodegenerative disorders. It operates under its parent company, Corundum Innovation, a Japanese-based investment firm.
Portfolio Companies
3
Website
corundumneuro.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Zoog.AI | Jul 2021 | Seed | Co-investor |
| Embr Labs | Dec 2020 | Early Funding | Lead |
| GrayMatters Health | Jan 2022 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Joy Ventures based?
Joy Ventures is headquartered in Herzliya, Tel Aviv District, Israel.
When was Joy Ventures founded?
Founding year information for Joy Ventures is not publicly available.
How many portfolio companies does Joy Ventures have?
Joy Ventures has 3 portfolio companies in Caplight's dataset.
What are some companies in Joy Ventures's portfolio?
Portfolio companies visible on Caplight include Zoog.AI, Embr Labs, GrayMatters Health.
What was Joy Ventures's most recent investment shown here?
Joy Ventures's most recent investment in this portfolio sample was in GrayMatters Health in 2022.
What sectors does Joy Ventures focus on?
Joy Ventures focuses on Healthcare & Life Sciences, Media, Entertainment & Gaming, Healthcare & Life Sciences, Consumer & Commerce, AI, Data & Cloud Infrastructure.
What company stages does Joy Ventures focus on?
Joy Ventures typically invests at the Early stage.